Zobrazeno 1 - 10
of 347
pro vyhledávání: ''
Autor:
Marije E. Weidema, Anke E M van Erp, Ingrid M.E. Desar, Mikio Masuzawa, Uta Flucke, Melissa H.S. Hillebrandt-Roeffen, PALGA-group, Winette T. A. van der Graaf, Yvonne M.H. Versleijen-Jonkers
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 147, 2579-2590
Journal of Cancer Research and Clinical Oncology, 147, 9, pp. 2579-2590
Journal of Cancer Research and Clinical Oncology, 147, 2579-2590
Journal of Cancer Research and Clinical Oncology, 147, 9, pp. 2579-2590
Purpose Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicat
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Journal of cancer research and clinical oncology, 147:779-792
Journal of cancer research and clinical oncology, 147:779-792
Purpose d,l-methadone (MET), an analgesic drug used for pain treatment and opiate addiction, has achieved attention from oncologists and social media as possible chemoensitizing agent in cancer therapy, notably brain cancer (glioblastoma multiforme,
Autor:
Dinja T. Kruger, Karin Beelen, Vincent van der Noort, Sabine C. Linn, Joyce Sanders, Epie Boven, Mark Opdam, Bart de Valk, Michiel Nieuwenhuis
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Kruger, D T, Opdam, M, van der Noort, V, Sanders, J, Nieuwenhuis, M, de Valk, B, Beelen, K J, Linn, S C & Boven, E 2020, ' PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane ', Journal of Cancer Research and Clinical Oncology, vol. 146, no. 11, pp. 3013-3023 . https://doi.org/10.1007/s00432-020-03291-x
Journal of Cancer Research and Clinical Oncology, 146(11), 3013-3023. Springer Verlag
Kruger, D T, Opdam, M, van der Noort, V, Sanders, J, Nieuwenhuis, M, de Valk, B, Beelen, K J, Linn, S C & Boven, E 2020, ' PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane ', Journal of Cancer Research and Clinical Oncology, vol. 146, no. 11, pp. 3013-3023 . https://doi.org/10.1007/s00432-020-03291-x
Journal of Cancer Research and Clinical Oncology, 146(11), 3013-3023. Springer Verlag
Purpose Everolimus plus exemestane (EVE/EXE) is a registered treatment option for ER-positive, HER2-negative (ER +/HER2-) metastatic breast cancer (MBC), but resistance mechanisms limit efficacy. We aimed to find markers that might help select patien
Autor:
Mengmeng Zhu, Yuansheng Liu, Qiong Zhang, Yinan Yang, Wencong Tian, Lei Yang, Jie Liu, Liang Yang, Yanna Shen, Jing Li, Zhi Qi
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:93-103
In our previous study, we discovered that resveratrol (RSV) had potential tumor-promoting effect on pancreatic cancer (PaCa) via up-regulation of VEGF-B. Therefore, we assumed that a pharmacological inhibitor of VEGF-B should potentiate the anti-tumo
Autor:
Boris Duchemann, Jean-Baptiste Assié, Kader Chouahnia, Gaetan Des Guetz, Thierry Landre, Christos Chouaid
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:3333-3339
Erlotinib is indicated as first-line treatment for patients with non-small-cell lung cancer (NSCLC) harboring an epidermal growth-factor–receptor (EGFR) mutation. Addition of a vascular endothelial growth factor (VEGF) inhibitor (anti-VEGF) in comb
Autor:
Gemma Bruera, Ioannis Papasotiriou, Giammaria Fiorentini, Donatella Sarti, Enrico Ricevuto, Andrew R. Mackay, Francesco Masedu, Paola Palumbo, Marco Clementi, Marco Valenti, Stefano Guadagni, Panagiotis Apostolou, Aldo Victor Giordano
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background Hepatic artery infusion (HAI) and drug selection by liquid biopsy precision oncotherapy are under investigation for the multidisciplinary treatment of unresectable colorectal liver metastases (CRCLM) in progression after systemic therapy.
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:631-645
Tumor growth relies on the sufficient blood supply and continuously requires new blood vessels to maintain, which lead to vascular abnormalities (Folkman, N Engl J Med 285:1182–1186, 1971). Antiangiogenic therapy has emerged with the goal of normal
Autor:
Marcus Vetter, Kerstin Hoeck, Michael Friedlander, Siti Omar, Andreas Schoetzau, Neville F. Hacker, André B. Kind, Viola Heinzelmann-Schwarz, Kenneth J. Russell, Daniel Fink
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background Malignant mixed Mullerian tumors of endometrial (MMMT-E) and ovarian (MMMT-O) origin are associated with poor prognosis. Suggestively epithelial-driven tumors, their treatment has shifted from anthracycline or ifosfamide-based towards taxa
Autor:
Giorgio Minotti, Pier Luigi Zinzani
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose CD19 is a cell surface protein that is found on both healthy and malignant B cells. Accordingly, it has become an important target for novel treatments for non-Hodgkin lymphomas and B-cell leukaemia. Three anti-CD19 monoclonal antibodies with
Autor:
A. Pryalukhin, Moritz Kohn, Christian Veith, Rainer M. Bohle, Johannes Linxweiler, Kerstin Junker, Markus Hammer, Michael Stöckle, Stefanie Muhs, Matthias Saar
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 145:551-559
To generate and characterize 3D spheroid suspension cultures from radical prostatectomy (RP) specimens as a versatile model system for organ-confined prostate cancer (PCa). Cancerous tissue samples from RP specimens were excised by a uropathologist.